论文部分内容阅读
目的:总结肾集合管癌的临床病理特点、诊治方法及预后。方法:回顾性分析2005年2月及2011年7月收治的2例肾集合管癌患者的临床资料。结果:例1术后3个月发生肺转移,术后9个月死于多脏器功能衰竭。例2术后随访3个月,情况良好。结论:肾集合管癌是一种临床罕见、高度恶性的肿瘤,确诊依赖病理检查及免疫组织化学检测。本病以手术根治性治疗为主,术后易复发且转移较早,预后差。
Objective: To summarize the clinicopathological characteristics, diagnosis and treatment methods and prognosis of renal tubal carcinoma. Methods: The clinical data of 2 patients with renal aggregate carcinoma admitted in February 2005 and July 2011 were analyzed retrospectively. Results: Cases 1 lung metastases occurred 3 months after operation and died of multiple organ failure 9 months after operation. Example 2 Follow-up 3 months after surgery, in good condition. CONCLUSIONS: Renal tubal carcinoma is a clinically rare and highly malignant tumor that is diagnosed on pathology and immunohistochemistry. The disease is mainly radical surgery, postoperative recurrence and metastasis earlier, the prognosis is poor.